Psychiatric disorders commonly co-exist with the diagnosis of chronic kidney disease (CKD). Research on depression and CKD has increased to a great extent. Multiple studies have demonstrated that depression is more prevalent in CKD and that end-stage renal disease is a robust risk factor for adverse outcomes such as hospitalization and mortality, yet these are often underdiagnosed or untreated. This review provides a selective overview on the prevalence rates of depression and anxiety in patients with CKD and across renal replacement therapies, the factors most consistently associated with symptoms of distress and their clinical implications. Finally, treatment and management strategies from relevant literature are appraised and discussed.
CITATION STYLE
Goh, Z. S., & Griva, K. (2018, March 12). Anxiety and depression in patients with end-stage renal disease: Impact and management challenges – A narrative review. International Journal of Nephrology and Renovascular Disease. Dove Medical Press Ltd. https://doi.org/10.2147/IJNRD.S126615
Mendeley helps you to discover research relevant for your work.